Navigation Links
UC Davis discovery offers hope for treating kidney cancer
Date:12/23/2008

Kidney cancer is typically without symptoms until it has spread to other organs, when it is also the most difficult to treat. Newer chemotherapies show great promise for extending survival during later disease stages, but they can also be highly toxic.

In one of the first discoveries of its kind, UC Davis Cancer Center researchers have identified ways to block a cancer gene's own repair mechanism and, in so doing, help make chemotherapy for kidney cancer more effective and better tolerated. The outcome is published in the current issue of Cancer Biology and Therapy.

"Cancer cells are notorious in their ability to rapidly create copies of themselves. While the latest medications slow down that process, they do not tend to be curative and have many side effects," said Robert Weiss, a UC Davis professor of nephrology and chief of nephrology at the Sacramento VA Medical Center. "We wanted to find ways to help make chemotherapeutics as effective as possible at the lowest doses possible."

Newer medications work by destabilizing cancer cells at the DNA level, which reduces their ability to replicate. Knowing that the p21 gene has an important role in restoring cancer cell DNA and potentially circumventing the benefits of those treatments, Weiss sought to identify compounds that could interrupt this pathway.

The team tested thousands of compounds and 12 were found to bind to the recombinant protein p21. Additional tests showed that three of those compounds decreased p21 expression, blocking kidney cancer cells' ability to mend and making them more responsive to DNA-damaging treatments.

"The results are very exciting, especially given how difficult kidney cancer has so far been to treat," Weiss said. "Our work offers hope that in the future these p21 inhibitors can be refined and used in concert with other conventional as well as novel cancer treatments to increase the comfort and life spans of patients with kidney cancer."

For future studies, Weiss will focus on the three candidate compounds to determine the lowest possible concentrations at which they remain effective and to further optimize their anti-cancer properties. He will then test those compounds with standard treatments in animal models and, ultimately, in human trials.

"The goal is to find new approaches to treating a cancer for which few options currently exist and make those approaches available in clinical settings as quickly as possible," he said.


'/>"/>

Contact: Karen Finney
karen.finney@ucdmc.ucdavis.edu
916-734-9064
University of California - Davis - Health System
Source:Eurekalert

Related biology news :

1. UC Davis team refines cancer treatments to reduce potential nerve damage
2. UC Davis researchers exploring gene therapy to fight AIDS
3. UC Davis researchers discover Achilles heel in pancreatic cancer
4. UC Davis researchers discover a key to aggressive breast cancer
5. UC Davis chemical ecologist wins major award
6. UC Davis researchers discover new drug target for inflammatory disease
7. UC Davis researchers define characteristics, treatment options for XXYY syndrome
8. UC Davis researcher leads climate-change discovery
9. UC Davis stem researchers demonstrate safety of gene therapy using adult stem cells
10. UC Davis researchers discover how HIV turns food-poisoning into lethal infection
11. UC Davis bird-flu expert calls for changes in early-warning system
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2020)... ... May 06, 2020 , ... ... Texas, http://www.brevitest.com ) will become the latest out-of-state company to partner ... Inner Harbor. , Brevitest has developed a point-of-care analyzer capable of accurately ...
(Date:5/1/2020)... (PRWEB) , ... May 01, 2020 , ... More than ... Comprehensive Cancer Center’s High-Risk Cancer Program, which is led by two genetic counselors. , ... solutions, today announced it is teaming up with UConn’s High Rick Program to ensure ...
(Date:4/28/2020)... SEATTLE, and FT. LAUDERDALE, Fla. (PRWEB) , ... ... ... announces its official launch. The first-of-its-kind category-defining service was started by three teenagers ... to make a change in the world during the time of great need ...
Breaking Biology News(10 mins):
(Date:5/5/2020)... ... May 05, 2020 , ... Smart ... launch of its iGlucose® LTE Cat-M Cellular Connected Diabetes Blood Glucose ... technology, the industry’s newest and broadest cellular connectivity available, to provide patients with ...
(Date:4/26/2020)... ... April 23, 2020 , ... Indegene Omnipresence, Inc. announced the ... and services for use on Microsoft Azure. The customer experience management (CXM) technology ... for a built-for-purpose customer engagement capability to use in their commercial or medical ...
(Date:4/22/2020)... ... April 20, 2020 , ... Global molecular diagnostics company ... Omixon’s founder and chairman Dr. Attila Berces returns as CEO. Outgoing CEO Dr. ... 2014 before stepping into the CEO role in 2017. , In concert ...
(Date:4/22/2020)... , ... April 21, 2020 , ... ... their work through COVID-19. Many clinical trial teams are working remotely and have ... Science wants to help researchers continue their research during this uncertain time by ...
Breaking Biology Technology: